摘要:
目的:探讨重症胰腺炎(SAP)患者辅助应用持续肾脏替代治疗(CRRT)的临床效果. 方法:选取南京军区福州总医院2000年5月~2013年11月间收治的SAP病例资料进行回顾性分析,20例采用常规治疗+CRRT辅助治疗,为CRRT组;另随机选取同期收治的19例仅采用常规治疗方法的病例,作为对照组,观察两组临床疗效和转归. 结果:CRRT组与对照组相比,治疗前一般情况及各项检查指标均无明显差异(P>0.05;治疗后24h,72h,5d不同时间点,CRRT组与对照组比较:血钙升高(F=4.455,5.724,4.506,P=0.042,0.022,0.041)、血淀粉酶降低(F=4.613,7.904,6.732,P=0.038,0.008,0.013),血肌酐降低(F=5.022,9.909,8.313,P=0.031,0.003,0.007)、尿素氮降低(F=4.853,4.687,5.237,P=0.034,0.037,0.028);C反应蛋白降低(F=4.693,6.617,7.589,P=0.037,0.014,0.009);体温降低(F=5.806,5.365,6.891,P=0.021,0.026,0.013)、心率减慢(F=6.410,4.775,5.379,P=0.016,0.035,0.026)、平均动脉压升高(F=4.780,4.833,4.715,P=0.035,0.034,0.036);APACHEII评分降低(F=5.760,4.517,5.874,P=0.022,0.040,0.020)。住院期间病死率比较:CRRT组低于对照组(10%vs42%,x2=5.267,P=0.022)。 结论:CRRT是辅助治疗SAP患者的有效手段之一,可能对SAP患者有改善预后的作用。